Jpmorgan Chase & Co »

Augmedix shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $295k 50k 5.85
2023-09-30 $14k 2.8k 5.15

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Augmedix

Redmile Group
Samjo Management
Divisadero Street Capital Management
Perkins Capital Management
Vanguard Group
Caption Management
Russell Investments
G2 Investment Partners Management
Essex Investment Management
American Financial Group
Balyasny Asset Management
Kennedy Capital Management
Millennium Management
Susquehanna International
Point72 Asset Management

View all funds holding Augmedix